E Fund Management’s Kura Oncology KURA Stock Holding History

E Fund Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$132K	Sell	12,054 -4,810	-29%	-$45.4K	﹤0.01%	469
2026 Q1	$137K	Buy	+16,864	New	+$145K	﹤0.01%	464
2025 Q2	$67.5K	Sell	11,702 -550	-4%	-$3.37K	﹤0.01%	385
2025 Q1	$80.9K	Buy	12,252 +1,951	+19%	+$15.2K	﹤0.01%	389
2024 Q4	$89.7K	Buy	+10,301	New	+$148K	﹤0.01%	380
2024 Q2	–	Sell	-14,710	Closed	-$314K	–	344
2024 Q1	$314K	Buy	+14,710	New	+$286K	0.02%	272
2023 Q4	–	Sell	-11,929	Closed	-$109K	–	316
2023 Q3	$109K	Buy	11,929 +1,301	+12%	+$13.2K	0.01%	281
2023 Q2	$112K	Sell	10,628 -4,960	-32%	-$58.7K	0.01%	299
2023 Q1	$191K	Sell	15,588 -1,585	-9%	-$19.8K	0.01%	304
2022 Q4	$213K	Sell	17,173 -2,207	-11%	-$32.1K	0.02%	292
2022 Q3	$265K	Buy	19,380 +8,807	+83%	+$136K	0.02%	253
2022 Q2	$194K	Buy	+10,573	New	+$152K	0.02%	302

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

E Fund Management's KURA Position: Q2 2026 in Review

E Fund Management reduced its Kura Oncology (KURA) stake by 29% in Q2 2026, selling an estimated $45.4K and leaving 12,054 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #469.

E Fund Management first reported a position in KURA in Q2 2022 and has held it in 12 quarters since. The position peaked at $314K in Q1 2024. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

E Fund Management held 12,054 shares of Kura Oncology worth $132K as of Q2 2026.
E Fund Management sold 4,810 Kura Oncology shares in Q2 2026, an estimated $45.4K.
Kura Oncology made up ﹤0.01% of E Fund Management's portfolio in Q2 2026, its #469 holding.
E Fund Management first reported a position in Kura Oncology in Q2 2022 and has held it in 12 quarters since.
E Fund Management's Kura Oncology position peaked at $314K in Q1 2024.
220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.